What is CLLS's gross margin?

Cellectis (CLLS) has a gross margin of 16% and a net margin of -417%.

What is CLLS's P/E ratio?

Track Cellectis (CLLS) P/E ratio, ROE, and valuation metrics over time.

Where can I see CLLS's full financials?

See Cellectis (CLLS) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Cellectis (CLLS) Financials — Revenue, Earnings, Cash Flow

Also trades as: ALCLS.PA (PAR) · $vol 0M · CMVLF (OTC) · $vol 0M

$1.43

+0.03 (+2.14%)

Weekly Expected Move ±23.0%

$1 $1 $1 $2 $2

NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 24 · $143.6M mcap · 86M float · 0.078% daily turnover · Short 47% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

📊 Key Metrics

TTM

$57M

Revenue

+0.5% YoY

$-65M

Net Income

-10.8% YoY

$-44M

Free Cash Flow

-20.4% YoY

15.6%

Gross Margin

-487.4%

Op. Margin

-417.3%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-94.6%

ROA-21.0%

ROIC118.6%

Valuation

P/E-2.2

P/B3.5

EV/EBITDA-4.0

Leverage

Debt/Equity2.06

Current Ratio1.37

Interest Cov.-8.9x

Quality Scores

Piotroski F2/9

Altman Z-1.28

Beneish M-2.03